Clinical Trial Update: Validation Study: Extended Wear Performance of the Zio Monitor - SHASTA II [NA]

View source ↗

Summary

A status update on the SHASTA II validation study of the Zio Monitor by iRhythm Technologies for cardiac arrhythmia; the study is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Arrhythmia

Drugs mentioned

• Zio Monitor

Snippet

Sponsor: iRhythm Technologies, Inc. | Conditions: Cardiac Arrhythmia | NA | Status: ACTIVE_NOT_RECRUITING